SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-038211
Filing Date
2013-05-07
Accepted
2013-05-07 15:57:15
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-8376_110q.htm 10-Q 952186
2 EX-10.1 a13-8376_1ex10d1.htm EX-10.1 14282
3 EX-31.1 a13-8376_1ex31d1.htm EX-31.1 9667
4 EX-31.2 a13-8376_1ex31d2.htm EX-31.2 9710
5 EX-32.1 a13-8376_1ex32d1.htm EX-32.1 7338
  Complete submission text file 0001104659-13-038211.txt   9429612

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isis-20130331.xml EX-101.INS 1246085
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isis-20130331.xsd EX-101.SCH 111608
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isis-20130331_cal.xml EX-101.CAL 42594
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT isis-20130331_lab.xml EX-101.LAB 1723816
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isis-20130331_pre.xml EX-101.PRE 845139
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isis-20130331_def.xml EX-101.DEF 546983
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 13819863
SIC: 2834 Pharmaceutical Preparations